ADCLEC.syn1 CAR T cells
23-002
Phase 1 mab active
Quick answer
ADCLEC.syn1 CAR T cells for Acute Myeloid Leukemia is a Phase 1 program (mab) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- active